Virtual and in-person event, Bridging Basic Science and Liver Disease, brings together hundreds of leading biomedical ...
Cybersecurity retains its place as the top-ranked risk and top area of audit effort: 82% of internal auditors rated this risk as "very high" or "higher than average" for their organizations in 2025, ...
Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.
Administrative tasks are the leading cause of stress (49%), followed by classroom management (48%) and concerns over student ...
NAGPUR, India, Nov. 14, 2024 (GLOBE NEWSWIRE) -- At the Haematocon 2024 conference in Nagpur, India, Hemex Health announced new product offerings for the Company’s Gazelle™ Diagnostic Device that will ...
Celestine Achi is an AI innovator and CEO of Cihan Media, the pioneer of the TABS-D Framework, and founder of Cihan Digital ...
Assured Guaranty (AG)* has insured $920 million of senior Special Facilities Revenue Bonds issued by the New York Transportation Development Corporation in connection with the JFK Airport Terminal 6 ...
MedAllies is proud to be Certifiedâ„¢ by Great Place To Work® for the second year in a row. The prestigious award is based entirely on what current employees say about their experience working at ...
Artificial intelligence, or AI, is significantly impacting the world of digital signage software, including the innovative solutions offered by Kitcast. AI has the potential to completely transform ...
If you believe in progress, the future of work is hard to understand. It isn’t clear from today’s perspective which direction technology will take. Every era seems to invent a future that doesn’t ever ...
Participants should dial in at least ten minutes before the start of the conferece call. A live webcast of the conference call and financial results will be ...
Dr. Matt Barnes, Executive Officer, President of Nxera Pharma UK and Head of R&D Dr. Makoto Sugita, Executive Officer, Chief Medical Officer (CMO) and President of Nxera Pharma Japan Hironoshin Nomura ...